Glaucoma induced by periorbital topical steroid use - A rare complication

Clinical and Experimental Dermatology

Volumn 29, Issue 6, 2004, Pages 617-619

  Sahni, D ^a   Darley, C R ^b   Hawk, J L M ^c  

^a EALING HOSPITAL   (United Kingdom)

^b UK   (United Kingdom)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE DIPROPIONATE; STEROID;

ADULT; ARTICLE; CASE REPORT; ECZEMA; EYELID; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; LONG TERM CARE; OPHTHALMOLOGY; PATIENT EDUCATION; PERIORBITAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RARE DISEASE; STEROID THERAPY; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ADULT; BETAMETHASONE; DRUG ADMINISTRATION SCHEDULE; ECZEMA; EYELID DISEASES; FACIAL DERMATOSES; FEMALE; GLAUCOMA; GLUCOCORTICOIDS; HUMANS; VISION DISORDERS;

EID: 9644290705     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2004.01610.x     Document Type: Article

References (8)

1. Nielsen NV, Sorensen PN. Glaucoma induced by application of corticosteroids to the periorbital region. Arch Dermatol 1978; 114: 953-4.
2. Aggarwal RK, Potamitis T, Chong NHV, Guarro M, Shah P, Kheterpal S. Extensive visual loss with topical facial steroids. Eye 1993; 7: 664-6.
3. Goldman H. Cortisone glaucoma. Arch Opthalmol 1962; 68: 621-6.
4. Cubey RB. Glaucoma following the application of corticosteroid to the skin of the eyelid. Br J Dermatol 1976; 95: 207-8.
5. McLean CJ, Lobo RF, Brazier DJ. Cataracts, glaucoma, and femoral avascular necrosis caused by topical corticosteroid ointment. Lancet 1995; 345: 330.
6. Vie R. Glaucoma and amaurosis associated with long term application of topical corticosteroids to the eyelids. Acta Derm Venereol (Stockh) 1980; 60: 541-2.
7. Zugerman C, Saunders D, Levit F. Glaucoma from topically applied steroids. Arch Dermatol 1976; 112: 1326.
8. Eisenlohr JE. Glaucoma following the prolonged use of topical steroid medication to the eyelids. J Am Acad Dermatol 1983; 8: 878-81.